Skip to main content

Clearstead Advisors, LLC

Position in GALT — Galectin Therapeutics Inc

CIK 842775 CLEVELAND, OH

Position in GALT

as of Mar 31, 2026 · filed May 6, 2026
Position Value
$16,740
-$8,220 QoQ
Shares Held
6,000
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Derivatives in GALT

reported options exposure · as of Dec 31, 2025
CallValue
$8,320
CallShares
2,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Clearstead Advisors, LLC holds $49,363,406 across 77 Biotechnology names. GALT ranks #29 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GALT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,740 6,000
2025-12-31 $24,960 6,000
2025-12-31 $8,320 2,000
2025-09-30 $25,440 6,000
2025-06-30 $12,660 6,000
2025-03-31 $7,320 6,000
2024-12-31 $7,740 6,000
2024-09-30 $8,250 3,000
2024-06-30 $6,780 3,000
2024-03-31 $7,170 3,000
2023-12-31 $4,980 3,000
2023-09-30 $5,760 3,000
2023-06-30 $2,160 1,500